Sign in

You're signed outSign in or to get full access.

James Sullivan

Chief Legal Officer at BIO KEY INTERNATIONALBIO KEY INTERNATIONAL
Executive

About James Sullivan

James D. Sullivan, 57, serves as BIO-key’s Senior Vice President of Strategy and Compliance and Chief Legal Officer (since February 2020); previously SVP Strategy & Business Development (2012–2018) and SVP Global Sales (Aug 2015–Dec 2016). He holds a J.D. with Honors from Georgia State University College of Law, is a member of the Georgia Bar, and has a Computer Science degree from Brown University; he is a recognized expert in privacy, cybersecurity, and biometric authentication, with ~20 years at BIO-key and >26 years in IT across Computer Associates, Platinum Technology, and Memco Software, working with major customers including AT&T, Israel Defense Forces, LexisNexis, NCR, and Omnicell . Company performance markers during the recent period: total shareholder return (value of $100 investment) declined from $26.43 (2022) to $7.53 (2023) to $4.29 (2024), while net loss improved from $11.91M (2022) to $8.52M (2023) to $4.30M (2024) .

Company Performance (context)

MetricFY 2022FY 2023FY 2024
Value of $100 Investment (TSR)$26.43 $7.53 $4.29
Net Loss ($USD)$11,909,903 $8,521,837 $4,300,692

Past Roles

OrganizationRoleYearsStrategic Impact
BIO-key International, Inc.SVP Strategy & Compliance; Chief Legal OfficerFeb 2020–present Legal leadership; strategy/compliance in identity, privacy, cybersecurity
BIO-key International, Inc.SVP Strategy & Business DevelopmentApr 2012–Dec 2018 Led strategy and business development; engagements with major customers/projects
BIO-key International, Inc.SVP Global SalesAug 2015–Dec 2016 Directed global sales during dual-role period

External Roles

OrganizationRoleYearsStrategic Impact
Computer AssociatesSecurity/identity-related IT rolesNot disclosedEnterprise security and identity management experience
Platinum TechnologySecurity/identity-related IT rolesNot disclosedEnterprise software and security implementation
Memco SoftwareSecurity/identity-related IT rolesNot disclosedCybersecurity/authentication implementation experience

Fixed Compensation

ComponentFY 2023FY 2024
Base Salary ($)$212,479 $223,250
Stock Awards (Grant-date fair value, $)$16,500 $22,500
All Other Compensation ($)$6,433 (incl. $5,102 commissions; $1,331 life insurance) $79,429 (incl. $78,632 commissions; $797 life insurance)
Total ($)$235,412 $325,179

Compensation philosophy: executives’ pay comprises base salary, annual performance-based cash bonus (historically tied to revenue milestones), and long-term equity; base comp was decreased effective Jan 16, 2023 and restored July 1, 2024, with RS awards in 2024 and 2023 recognizing revenue growth and the Swivel Secure integration .

Performance Compensation

Equity Awards (RSUs/Restricted Stock) – Grants and Vesting

Grant TypeGrant SizeVesting ScheduleReference
Restricted Stock (2024 grant under 2023 Plan)22,500 sharesVest in three equal annual installments starting July 31, 2025
Restricted Stock (additional award)1,667 sharesVest in two equal annual installments starting August 29, 2025
Unvested Shares at 12/31/202424,166 sharesMarket value $72,498 at $1.71/share on 12/31/2024

Option Awards – Status and Terms (as of 12/31/2024)

Exercisable Options (#)Exercise Price ($)Expiration
174282.243/23/2025
174169.923/21/2026
In-the-money value at 12/31/2024$0 (stock at $1.71)

Bonus metrics: historically based on revenue milestones; specific target weightings, actuals, and payouts were not disclosed .

Equity Ownership & Alignment

Beneficial Ownership – Multi-year view

As-of DateShares Beneficially OwnedPercent of Class
Apr 26, 202138,043 <1%
Apr 26, 202279,293 <1%
Jun 1, 2023110,500 1.2%
Oct 31, 2023618,000 4.4%
Jun 20, 202557,553 <1% (6,848,775 shares O/S)

2023 breakdown (context): included 18,750 options, 64,125 restricted shares (51,375 unvested), and 228,000 warrants within 60 days; share figures reflect reverse splits and offering-related issuances .
Pledging/hedging: no pledging disclosed; insider trading policy exists and is filed with the 2024 Form 10-K .

Vesting and Potential Selling Pressure (calendar)

DateInstrumentShares Vesting
Jul 31, 2025Restricted Stock~7,500 (1/3 of 22,500)
Aug 29, 2025Restricted Stock~833.5 (1/2 of 1,667)
Jul 31, 2026Restricted Stock~7,500 (2/3 cumulative of 22,500)
Aug 29, 2026Restricted Stock~833.5 (full of 1,667)
Jul 31, 2027Restricted Stock~7,500 (final tranche of 22,500)

Options are far out-of-the-money relative to 12/31/2024 stock price ($1.71), reducing near-term exercise/selling pressure .

Employment Terms

  • Agreement date: April 5, 2017; auto-renews for successive one-year terms unless the Company provides at least two months’ written notice (treated as termination without cause) .
  • Base salary: $225,000 since 2021, subject to compensation committee adjustments .
  • Severance (termination without cause): continuation of then-current base salary plus earned commissions for the greater of six months or the remaining months in the term .
  • Restrictive covenants: confidentiality; technical invention; non-competition and non-solicitation prohibiting competitive activity or dealings with current/prospective customers during employment and for one year thereafter .
  • Change-in-control: plan-level equity acceleration at the committee’s discretion—options become immediately exercisable; restricted stock fully vests; RSU/other stock-based award conditions lapse; plan definitions include asset sale, merger with <50% continuing vote, incumbent board majority change, or 40% beneficial ownership thresholds (2015 and 2023 plans) .

Related Party Transactions and Signals

  • Insider participation in 2023 public offering: Sullivan purchased 12,667 shares and warrants to purchase 12,667 shares for $39,000; his spouse purchased 3,173 shares and warrants for $9,993; offering price $3.15 per unit; CEO also participated .

Investment Implications

  • Pay-for-performance alignment: cash compensation includes sizable commissions; equity mix uses multi-year RS vesting through 2027, aligning incentives with longer-term value creation. Performance bonuses are revenue-milestone based, but detailed targets are not disclosed, limiting precision in pay-performance calibration .
  • Near-term supply overhang: scheduled vesting of ~9k shares in 2H25 and ~8.3k in 2026 may create incremental selling pressure; options are deeply out-of-the-money (strikes $169.92–$282.24 vs $1.71 at 12/31/2024), reducing exercise-driven supply risk .
  • Retention risk: severance is modest (six months plus earned commissions) with one-year non-compete/non-solicit; auto-renewal and multi-year vesting support retention, but limited severance suggests moderate transition flexibility for the company if performance goals change .
  • Ownership alignment: Sullivan’s beneficial ownership is <1% as of June 20, 2025; he and his spouse added exposure via the 2023 offering and warrants, signaling commitment, though reverse splits and capital raises have materially affected share counts over time .
  • Change-of-control economics: single-trigger equity acceleration subject to committee discretion is shareholder-unfriendly relative to double-trigger norms, potentially increasing payout sensitivity in M&A scenarios .